Literature DB >> 3434620

Minisculptured ossicle grafts versus implants: long-term results.

V Colletti1, F G Fiorino, V Sittoni.   

Abstract

The present study deals with 832 ossicular chain reconstruction procedures performed in 655 patients from January 1975 to December 1985. Homograft and autograft ossicles, intraoperatively minisculptured according to personal or traditional techniques, were used in 626 ears (75.2%). In the remaining 206 ears Plastipore or Proplast total or partial ossicular replacement prostheses were employed. The functional hearing results are evaluated as a function of length of follow-up, techniques used, and preoperative diagnosis. Short-term hearing gain is satisfactory and very similar for both ossicles and implants. Long-term observation however, shows, a progressive and systematic reduction of the postoperative hearing gain for both treatments. The long-term deterioration of hearing levels in ears receiving implants is more evident and dramatic than that observed in ears with ossicles. The difference is statistically significant. The causes of failure are evaluated based on both clinical data and findings at revision surgery.

Entities:  

Mesh:

Year:  1987        PMID: 3434620

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  3 in total

1.  Surgical management of middle ear cholesteatoma and reconstruction at the same time.

Authors:  Pedro Blanco; Francisco González; Jorge Holguín; Claudia Guerra
Journal:  Colomb Med (Cali)       Date:  2014-09-30

2.  Comparison of Titanium vs. Polycel Total Ossicular Replacement Prosthesis.

Authors:  Mohammad Faramarzi; Reza Jahangiri; Sareh Roosta
Journal:  Iran J Otorhinolaryngol       Date:  2016-03

3.  Psychometric characteristics of the chronic Otitis media questionnaire 12 (COMQ - 12): stability of factor structure and replicability shown by the Serbian version.

Authors:  Bojana Bukurov; Nenad Arsovic; Sandra Sipetic Grujicic; Mark Haggard; Helen Spencer; Jelena Eric Marinkovic
Journal:  Health Qual Life Outcomes       Date:  2017-10-23       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.